Ignite Creation Date:
2024-05-06 @ 10:03 AM
Last Modification Date:
2024-10-26 @ 12:24 PM
Study NCT ID:
NCT03157167
Status:
COMPLETED
Last Update Posted:
2020-07-16
First Post:
2017-05-04
Brief Title:
An Evaluation of Tc 99m Tilmanocept by Intravenous IV and Subcutaneous SC Injection in Kaposi Sarcoma KS
Sponsor:
Navidea Biopharmaceuticals
Organization:
Navidea Biopharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-30
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-04
First Submit QC Date:
May 16 2017
Study First Post Date:
2017-05-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-14
Last Update Post Date:
2020-07-16
Last Update Post Date Type:
ACTUAL